AZ in China joint venture

AstraZeneca Plc has entered into a partnership with the Chinese-government backed Future Industry Investment Fund (FIIF) to create a stand-alone, joint venture company called Dizal Pharmaceutical that will develop and commercialise new medicines in China.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom